| Item Type | Name |
|
Academic Article
|
Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors.
|
|
Academic Article
|
Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes.
|
|
Academic Article
|
Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy.
|
|
Academic Article
|
Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
|
|
Academic Article
|
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.
|
|
Academic Article
|
Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptors.
|
|
Academic Article
|
Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation.
|
|
Academic Article
|
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells.
|
|
Academic Article
|
Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma.
|
|
Academic Article
|
Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes.
|
|
Academic Article
|
Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy.
|
|
Academic Article
|
Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.
|
|
Academic Article
|
Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor elimination.
|
|
Academic Article
|
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.
|
|
Academic Article
|
High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells.
|
|
Academic Article
|
Ex vivo gene transfer for improved adoptive immunotherapy of cancer.
|
|
Academic Article
|
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.
|
|
Academic Article
|
Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation.
|
|
Academic Article
|
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor.
|
|
Academic Article
|
In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation.
|
|
Academic Article
|
Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12.
|
|
Academic Article
|
Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector function.
|
|
Academic Article
|
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation.
|
|
Academic Article
|
Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b.
|
|
Concept
|
Receptors, Antigen
|
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
T-Cell Antigen Receptor Specificity
|
|
Concept
|
Receptors, Antigen, T-Cell, gamma-delta
|
|
Academic Article
|
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15.
|
|
Academic Article
|
Kinetics of tumor destruction by chimeric antigen receptor-modified T cells.
|
|
Academic Article
|
Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity.
|
|
Academic Article
|
Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
|
|
Academic Article
|
Toward immunotherapy with redirected T cells in a large animal model: ex vivo activation, expansion, and genetic modification of canine T cells.
|
|
Academic Article
|
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.
|
|
Academic Article
|
Broadly-specific cytotoxic T cells targeting multiple HIV antigens are expanded from HIV+ patients: implications for immunotherapy.
|
|
Academic Article
|
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application.
|
|
Academic Article
|
CMV-specific T cells generated from na?ve T cells recognize atypical epitopes and may be protective in vivo.
|
|
Academic Article
|
Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency.
|
|
Academic Article
|
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs.
|
|
Academic Article
|
Clinical responses with T lymphocytes targeting malignancy-associated ? light chains.
|
|
Academic Article
|
Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer.
|
|
Academic Article
|
Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells.
|
|
Academic Article
|
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.
|
|
Academic Article
|
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells.
|
|
Academic Article
|
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma.
|
|
Academic Article
|
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
|
|
Academic Article
|
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells.
|
|
Academic Article
|
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1.
|
|
Academic Article
|
Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent.
|
|
Academic Article
|
Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells.
|
|
Academic Article
|
Transposon-modified antigen-specific T lymphocytes for sustained therapeutic protein delivery in vivo.
|
|
Academic Article
|
Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities.
|
|
Academic Article
|
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors.
|
|
Academic Article
|
Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells.
|
|
Grant
|
ENHANCING T CELL THERAPY OF CANCER
|
|
Academic Article
|
In?Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas.
|
|
Academic Article
|
T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy.
|
|
Academic Article
|
A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells.
|
|
Academic Article
|
T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells.
|
|
Academic Article
|
A Costimulatory CAR Improves TCR-based Cancer Immunotherapy.
|
|
Academic Article
|
Banking on virus-specific T cells to fulfill the need for?off-the-shelf cell therapies.
|
|
Academic Article
|
Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein-Barr Virus-Specific T-Cells.
|
|
Academic Article
|
Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing.
|
|
Academic Article
|
Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for Neuroblastoma.
|